Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyr4 and parC

被引：66

作者：

Gibreel, A

Sjögren, E

Kaijser, B

Wretlind, B

Sköld, O

机构：

[1] Univ Uppsala, Ctr Biomed, Dept Pharmaceut Biosci, Div Microbiol, S-75123 Uppsala, Sweden

[2] Univ Gothenburg, Dept Clin Bacteriol, Gothenburg, Sweden

[3] Karolinska Hosp, Bacteriol Lab, S-10401 Stockholm, Sweden

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 12期

关键词：

D O I：

10.1128/AAC.42.12.3276

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Quinolone resistance in clinical isolates of Campylobacter jejuni in Sweden increased more than 20-fold at the beginning of the 1990s. Resistance to 125 mu g of ciprofloxacin per ml in clinical isolates was associated with chromosomal mutations in C. jejuni leading to a Thr-86-Ile substitution in the gyrA product and a Arg-139-Gln substitution in the parC product.

引用

收藏

页码：3276 / 3278

页数：3

相关论文

共 24 条

[1] Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV [J].

Breines, DM ;

Ouabdesselam, S ;

Ng, EY ;

Tankovic, J ;

Shah, S ;

Soussy, CJ ;

Hooper, DC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :175-179

[2] EVIDENCE FOR AN EFFLUX PUMP IN MULTIDRUG-RESISTANT CAMPYLOBACTER-JEJUNI [J].

CHARVALOS, E ;

TSELENTIS, Y ;

HAMZEHPOUR, MM ;

KOHLER, T ;

PECHERE, JC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) :2019-2022

[3] ENDOGENOUS ACTIVE EFFLUX OF NORFLOXACIN IN SUSCEPTIBLE ESCHERICHIA-COLI [J].

COHEN, SP ;

HOOPER, DC ;

WOLFSON, JS ;

SOUZA, KS ;

MCMURRY, LM ;

LEVY, SB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1187-1191

[4] Adaptation to sulfonamide resistance in Neisseria meningitidis may have required compensatory changes to retain enzyme function: Kinetic analysis of dihydropteroate synthases from N-meningitidis expressed in a knockout mutant of Escherichia coli [J].

Fermer, C ;

Swedberg, G .

JOURNAL OF BACTERIOLOGY, 1997, 179 (03) :831-837

[5] GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF NORFLOXACIN RESISTANCE IN ESCHERICHIA-COLI [J].

HOOPER, DC ;

WOLFSON, JS ;

SOUZA, KS ;

TUNG, C ;

MCHUGH, GL ;

SWARTZ, MN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :639-644

[6] NEW TOPOISOMERASE ESSENTIAL FOR CHROMOSOME SEGREGATION IN ESCHERICHIA-COLI [J].

KATO, J ;

NISHIMURA, Y ;

IMAMURA, R ;

NIKI, H ;

HIRAGA, S ;

SUZUKI, H .

CELL, 1990, 63 (02) :393-404

[7]

Lagerstrom M, 1991, PCR Methods Appl, V1, P111

[8] ACTIVE EFFLUX MECHANISMS FOR ANTIMICROBIAL RESISTANCE [J].

LEVY, SB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :695-703

[9] SEROTYPING OF CAMPYLOBACTER-JEJUNI BY SLIDE AGGLUTINATION BASED ON HEAT-LABILE ANTIGENIC FACTORS [J].

LIOR, H ;

WOODWARD, DL ;

EDGAR, JA ;

LAROCHE, LJ ;

GILL, P .

JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 15 (05) :761-768

[10] Quinolone resistance from a transferable plasmid [J].

Martínez-Martínez, L ;

Pascual, A ;

Jacoby, GA .

LANCET, 1998, 351 (9105) :797-799